Old Web
English
Sign In
Acemap
>
Paper
>
4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2
4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2
2014
Mary-Ellen Taplin
Kim N. Chi
Franklin Chu
James S. Cochran
W.J. Edenfield
Emmanuel S. Antonarakis
U. Emmenegger
Elisabeth I. Heath
Arif Hussain
V.C. Njar
Alan J. Koletsky
David Uri Lipsitz
Luke T. Nordquist
Roberto Pili
Matthew Rettig
Oliver Sartor
Neal D. Shore
D. Marrinucci
Khalid Mamlouk
B. Montgomery
Keywords:
Galeterone
Castrate-resistant prostate cancer
Immunology
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]